Pneumococcal pneumonia in the UK—how herd immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate vaccine (PCV)

This publication has 26 references indexed in Scilit:

• The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccine
  Vaccine, 2003
• Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblings
  The Pediatric Infectious Disease Journal, 2003
• Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
  New England Journal of Medicine, 2003
• Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis
  BMJ, 2003
• Economic Evaluation of Vaccination Programs: The Impact of Herd-Immunity
  Medical Decision Making, 2003
• Safety and efficacy of the seven-valent pneumococcal conjugate vaccine: evidence from Northern California
  European Journal of Pediatrics, 2002
• Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia
  The Pediatric Infectious Disease Journal, 2002
• Diagnosis of pneumococcal pneumonia by polymerase chain reaction (PCR) in whole blood: a prospective clinical study
  Thorax, 2000
• Herd Immunity: History, Theory, Practice
  Epidemiologic Reviews, 1993
• HERD IMMUNITY: BASIC CONCEPT AND RELEVANCE TO PUBLIC HEALTH IMMUNIZATION PRACTICES1
  American Journal of Epidemiology, 1971